ImmunologybioRxivPreprint
Interleukin-36 promotes systemic Type-I IFN responses in severe psoriasis.
Marika Catapano, Marta Vergnano, Marco Romano…·Francesca Capon
The paper identifies an IL-36/TLR-9/Type-I IFN axis that drives systemic inflammation in psoriasis, offering a potential therapeutic target.
DOI 10.1101/496851